Table 2.

Correlation Between The Clinical Variables And PES1 Expression In Patients

Features	Variables	N	PES1 (%)		χ2	P
High	Low
Vital status	Survival	243	107 (57.5)	136 (72.7)	9.489	0.002067
Death	130	79 (42.5)	51 (27.3)
T classification	T1	182	85 (45.7)	97 (51.9)	2.579	0.76461
	T2	95	50 (26.9)	45 (24.1)
	T3	80	43 (23.1)	37 (19.8)
	T4	13	7 (3.8)	6 (3.2)
Tx	1	0 (0.0)	1 (0.5)
N classification	N0	253	133 (71.5)	120 (64.2)	3.718	0.293629
	N1	4	1 (0.5)	3 (1.6)
Nx	115	52 (28.0)	63 (33.7)
M classification	M0	267	135 (72.6)	132 (70.6)	0.188	0.910332
	M1	4	2 (1.1)	2 (1.1)
Mx	102	49 (26.3)	53 (28.3)
Gender	Female	121	51 (27.4)	70 (37.4)	4.267	0.03887
Male	252	135 (72.6)	117 (62.6)
Radiation therapy	No	341	166 (89.2)	175 (93.6)	2.322	0.3132
Yes	9	6 (3.2)	3 (1.6)
Histological type	Fibrolamellar carcinoma	3	0 (0.0)	3 (1.6)	3.143	0.207738
	Hepatocellular carcinoma	363	182 (97.8)	181 (96.8)
Hepatocholangio-carcinoma (mixed)	7	4 (2.2)	3 (1.6)
Residual tumor	R0	326	164 (88.2)	162 (86.6)	3.991	0.40729
	R1	17	8 (4.3)	9 (4.8)
	R2	1	1 (0.5)	0 (0.0)
Rx	22	8 (4.3)	14 (7.5)
Race	American Indian or Alaska native	2	2 (1.1)	0 (0.0)	13.765	0.008083
	Asian	159	95 (51.1)	64 (34.2)
	Black or African American	17	7 (3.8)	10 (5.3)
White	185	77 (41.4)	108 (57.8)
Age	≤55	125	64 (34.4)	61 (32.6)	4.332	0.114656
>55	244	118 (63.4)	126 (67.4)
Stage	I	172	83 (44.6)	89 (47.6)	2.016	0.732797
	II	87	48 (25.8)	39 (20.9)
	III	85	43 (23.1)	42 (22.5)
IV	5	2 (1.1)	3 (1.6)

Note: Bold values indicate P<0.05 and are statistically significant.